Swanson L
Front Pharmacol. 2018; 9:172.
PMID: 29568270
PMC: 5853825.
DOI: 10.3389/fphar.2018.00172.
Carhart-Harris R, Nutt D
J Psychopharmacol. 2017; 31(9):1091-1120.
PMID: 28858536
PMC: 5606297.
DOI: 10.1177/0269881117725915.
Nichols D
Pharmacol Rev. 2016; 68(2):264-355.
PMID: 26841800
PMC: 4813425.
DOI: 10.1124/pr.115.011478.
McCorvy J, Roth B
Pharmacol Ther. 2015; 150:129-42.
PMID: 25601315
PMC: 4414735.
DOI: 10.1016/j.pharmthera.2015.01.009.
Asor E, Ben-Shachar D
World J Psychiatry. 2013; 2(6):124-33.
PMID: 24175178
PMC: 3782191.
DOI: 10.5498/wjp.v2.i6.124.
Serotonergic hallucinogens as translational models relevant to schizophrenia.
Halberstadt A, Geyer M
Int J Neuropsychopharmacol. 2013; 16(10):2165-80.
PMID: 23942028
PMC: 3928979.
DOI: 10.1017/S1461145713000722.
From the prodrome to chronic schizophrenia: the neurobiology underlying psychotic symptoms and cognitive impairments.
Howes O, Fusar-Poli P, Bloomfield M, Selvaraj S, McGuire P
Curr Pharm Des. 2012; 18(4):459-65.
PMID: 22239576
PMC: 3662992.
DOI: 10.2174/138161212799316217.
Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines.
Winter J
Psychopharmacology (Berl). 2008; 203(2):251-63.
PMID: 18979087
DOI: 10.1007/s00213-008-1356-8.
The behavioral pharmacology of hallucinogens.
Fantegrossi W, Murnane K, Reissig C
Biochem Pharmacol. 2007; 75(1):17-33.
PMID: 17977517
PMC: 2247373.
DOI: 10.1016/j.bcp.2007.07.018.
Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.
Benneyworth M, Smith R, Barrett R, Sanders-Bush E
Psychopharmacology (Berl). 2005; 179(4):854-62.
PMID: 15645221
DOI: 10.1007/s00213-004-2108-z.
Modification by drugs of the response of the rat's uterus to adrenaline.
Holzbauer M, Vogt M
Br J Pharmacol Chemother. 1955; 10(2):186-90.
PMID: 14389659
PMC: 1509488.
DOI: 10.1111/j.1476-5381.1955.tb00081.x.
The action of lysergic acid diethyl-amide on mammalian cholinesterases.
Thompson R, Tickner A, Webster G
Br J Pharmacol Chemother. 1955; 10(1):61-5.
PMID: 14351688
PMC: 1509465.
DOI: 10.1111/j.1476-5381.1955.tb00061.x.
Biochemical observations on LSD-25 and Deseril.
DOEPFNER W
Experientia. 1962; 18:256-7.
PMID: 13886913
DOI: 10.1007/BF02148217.
[On the substance liberated in anaphylactic and allergic reaction].
Engelhardt G, Schwabe U
Klin Wochenschr. 1960; 38:145-52.
PMID: 13820339
DOI: 10.1007/BF01481232.
The etiology of schizophrenia. A review.
Ferreira A
Calif Med. 1961; 94:369-77.
PMID: 13699087
PMC: 1574422.
Does the public health laboratory have a role in mental illness.
Buchbinder L, Ferguson A
Am J Public Health Nations Health. 1958; 48(4):473-83.
PMID: 13521088
PMC: 1551573.
DOI: 10.2105/ajph.48.4.473.
Some central actions of 5-hydroxytryptamine and various antagonists.
Gaddum J, Vogt M
Br J Pharmacol Chemother. 1956; 11(2):175-9.
PMID: 13329335
PMC: 1509579.
DOI: 10.1111/j.1476-5381.1956.tb01049.x.
The effect of drugs on the amounts of substance P and 5-hydroxytryptamine in mammalian brain.
PAASONEN M, Vogt M
J Physiol. 1956; 131(3):617-26.
PMID: 13320358
PMC: 1363478.
DOI: 10.1113/jphysiol.1956.sp005486.
HYDROXYTRYPTAMINE.
Br Med J. 1956; 1(4977):1222-3.
PMID: 13316116
PMC: 1979917.
5-Hydroxytryptamine in normal human platelets.
Hardisty R, STACEY R
J Physiol. 1955; 130(3):711-20.
PMID: 13278930
PMC: 1363408.
DOI: 10.1113/jphysiol.1955.sp005437.
